Cargando…

Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis

As an obligate aerobe, Mycobacterium tuberculosis uses its electron transport chain (ETC) to produce energy via oxidative phosphorylation. This pathway has recently garnered a lot of attention and is a target for several new antimycobacterials. We tested the respiratory adaptation of M. tuberculosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berube, Bryan J., Parish, Tanya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740367/ https://www.ncbi.nlm.nih.gov/pubmed/29061760 http://dx.doi.org/10.1128/AAC.01677-17

Ejemplares similares

Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors
por: Berube, Bryan J., et al.
Publicado: (2019)

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023)

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023)

Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones
por: Basarab, Gregory S., et al.
Publicado: (2022)

Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating Mycobacterium abscessus
por: Berube, Bryan J., et al.
Publicado: (2018)

A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease
por: Negatu, Dereje A., et al.
Publicado: (2022)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

8‐Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis
por: Odingo, Joshua O., et al.
Publicado: (2019)

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
por: Palencia, Andrés, et al.
Publicado: (2016)

Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis
por: Kim, Ju Sang, et al.
Publicado: (2022)

Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model
por: Robertson, Gregory T., et al.
Publicado: (2019)

Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis
por: Bonnett, Shilah, et al.
Publicado: (2023)

InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis
por: Flint, Lindsay, et al.
Publicado: (2020)

Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
por: Madani, Abdeldjalil, et al.
Publicado: (2022)

Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
por: Li, Si-Yang, et al.
Publicado: (2017)

Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis
por: Early, Julie, et al.
Publicado: (2018)

Epetraborole Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Sodium Tetraphenylborate Displays Selective Bactericidal Activity against Neisseria meningitidis and N. gonorrhoeae and Is Effective at Reducing Bacterial Infection Load
por: Bernet, Eve, et al.
Publicado: (2021)

ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate
por: Xie, Min, et al.
Publicado: (2023)

A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis
por: Early, Julie V., et al.
Publicado: (2019)

Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination
por: Pryjma, Mark, et al.
Publicado: (2018)

Rifabutin Is Active against Mycobacterium abscessus in Mice
por: Dick, Thomas, et al.
Publicado: (2020)

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
por: Walter, Nicholas D., et al.
Publicado: (2023)

Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2022)

Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2022)

Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus
por: Choules, Mary P., et al.
Publicado: (2019)

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies
por: Zhang, Nan, et al.
Publicado: (2020)

Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
por: Hu, Yanmin, et al.
Publicado: (2016)

Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae
por: Thwaites, M., et al.
Publicado: (2018)

Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis
por: Shelton, Catherine, et al.
Publicado: (2022)

Destabilization of α-Helical Structure in Solution Improves Bactericidal Activity of Antimicrobial Peptides: Opposite Effects on Bacterial and Viral Targets
por: Ulaeto, David O., et al.
Publicado: (2016)

Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832
por: Dawson, Rodney, et al.
Publicado: (2023)

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
por: Diacon, Andreas H., et al.
Publicado: (2020)

TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus
por: Sarathy, Jickky Palmae, et al.
Publicado: (2020)

First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment
por: Tenero, David, et al.
Publicado: (2019)

Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats
por: Ireson, C R, et al.
Publicado: (2004)

In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment
por: Singh, Ragini, et al.
Publicado: (2015)

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases
por: Deshpande, Devyani, et al.
Publicado: (2016)

Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB
por: Chandrasekera, N. Susantha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_euvqs5lema95h9r6cso7reopt4